Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027947 (
neutropenia
)
17,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The aim of this investigation was to obtain information about the composition and the morphology of the microorganisms that inhabit the root surface of a patient with chronic
neutropenia
and severe and progressive periodontitis. In addition, gingival biopsies were studied by both scanning and transmission electron microscopy (SEM and
TEM
) to look for bacteria within the gingiva. Dark field microscopy (DFM) revealed 50% spirochetes, 30% motile rods, and 20% coccoid forms. Fourteen extracted teeth studied by SEM showed that the distribution of different bacterial morphotypes varies along the root surface and spirochetes are the prevailing bacteria on the most apically located plaque.
TEM
analyses of gingival tissue revealed no bacterial invasion within the gingiva. This study suggests that spirochetes may play an important role in the etiology of periodontitis associated with chronic
neutropenia
. In spite of neutropenic status, there was no bacterial invasion into the gingiva, suggesting that host reaction to dental plaque has not been abolished in this condition.
...
PMID:Periodontitis in a patient with chronic neutropenia. 277 3
Thirteen patients who had 16 episodes of bacteremia were observed between 1993 and 1997 in a pediatric oncology ward with a high background isolation rate of cefotaxime- or aztreonam-resistant gram-negative bacteria. Four blood isolates were Escherichia coli and 12 were Klebsiella pneumoniae, and these isolates harbored extended-spectrum beta-lactamases (ESBLs). All episodes of bacteremia were nosocomial, all except one of the episodes occurred in neutropenic patients, and all patients were treated with piperacillin or ceftazidime with amikacin and cefazolin prior to the onset of bacteremia. Nine of 13 patients were receiving extended-spectrum beta-lactam treatment when the bacteremias caused by ESBL producers occurred. Molecular studies revealed that four K. pneumoniae SHV-2-producing isolates from 1994 were of the same clone. Other ESBL producers, including six that carried both
TEM
-1 and SHV-5, five that carried SHV-5, and one that carried SHV-2 alone, were unrelated. In conclusion, SHV-5 was present in 11 of the 16 isolates and coexisted with
TEM
-1 in 6 isolates. Acquisition of resistance genes probably occurred under antibiotic selection pressure. This study highlights the importance of routine checks for and detection of ESBL producers. Effective therapy against ESBL producers should be considered early for children who have malignancies and
neutropenia
and who are septic, despite treatment with a regimen that includes an extended-spectrum beta-lactam, in a clinical setting of an increased incidence of ESBL-producing bacteria.
...
PMID:Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. 1056 24